Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Blood Advances|September 30, 2025
Outcome of patients with mantle cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T study by LYSA GroupMarion Aymard, Morgane Cheminant, Roch Houot, et al.
The Lancet. Haematology|March 5, 2017
Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trialJeffrey A Jones, Tadeusz Robak, Jennifer R Brown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 28, 2011
The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL studyCatherine Thieblemont, Josette Briere, Nicolas Mounier, et al.
Haematologica|May 7, 2011
Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELAOlivier Fitoussi, Karim Belhadj, Nicolas Mounier, et al.
Oncoimmunology|November 1, 2021
Phased differentiation of γδ T and T CD8 tumor-infiltrating lymphocytes revealed by single-cell transcriptomics of human cancersJuan-Pablo Cerapio, Marion Perrier, Camille-Charlotte Balança, et al.
Blood|March 9, 2017
Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphomaCharles Herbaux, Jordan Gauthier, Pauline Brice, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 24, 2019
Single-cell RNA sequencing unveils the shared and the distinct cytotoxic hallmarks of human TCRVδ1 and TCRVδ2 γδ T lymphocytesGabriele Pizzolato, Hannah Kaminski, Marie Tosolini, et al.
Cancer|March 23, 2019
Long-term fatigue in survivors of non-Hodgkin lymphoma: The Lymphoma Study Association SIMONAL cross-sectional studyNicolas Mounier, Sabine Anthony, Raphaël Busson, et al.
Bulletin Du Cancer|February 19, 2017
[Conduct of epidemiologic studies in French cancer survivors: Methods, difficulties encountered and solutions provided. Lessons learned from the SIMONAL study on long-term toxicities after non-Hodgkin lymphoma treatment]Sabine Anthony, Pierre Hebel, André Garrel, et al.
Hematological Oncology|November 24, 2016
First-line therapy for chronic lymphocytic leukemia in patients older than 79 years is feasible and achieves good results: A FILO retrospective studyGodelieve Meunier, Loic Ysebaert, Phi Linh Nguyen-Thi, et al.
Pageof 7